Results 201 to 210 of about 615,527 (345)

EU-ACP Economic Partnership Agreements and ACP Integration [PDF]

open access: yes
The direct effects of EPAs on ACP countries arise from the requirement to eliminate tariffs on most imports from the EU. While consumers gain from cheaper imports, the government losses tariff revenue and producers face increased completion, implying ...
Chris Milner   +2 more
core  

Lactylation‐Driven YTHDC1 Alleviates MASLD by Suppressing PTPN22‐Mediated Dephosphorylation of NLRP3

open access: yesAdvanced Science, EarlyView.
In MASLD, YTHDC1 undergoes increased lactylation and ubiquitination, reducing its expression. AARS1 mediates lactylation at lysine 565, while disrupted binding to LDHA further promotes lactylation, suppressing YTHDC1. This downregulation enhances PTPN22 mRNA stability, leading to NLRP3 dephosphorylation and activation, which exacerbates inflammation ...
Feng Zhang   +16 more
wiley   +1 more source

Global nutritional equity of fishmeal and aquaculture trade flows. [PDF]

open access: yesProc Natl Acad Sci U S A
Elsler LG   +7 more
europepmc   +1 more source

U.S. --MEXICO FOOD SYSTEMS AND THE TOMATO TRADE DISPUTE [PDF]

open access: yes
Mexican produce exports into the U.S. increased considerably during the latter months of 1995 and the first nine months of 1996. Because of these increased imports, Florida tomato growers requested the executive branch of the U.S. government and Congress
Almonte-Alvarez, Jaime   +1 more
core   +1 more source

CDK4/6 Inhibition Induces CD8+ T Cell Antitumor Immunity via MIF‐Induced Functional Orchestration of Tumor‐Associated Macrophages

open access: yesAdvanced Science, EarlyView.
CDK4/6 inhibition promotes CD8+ T cell expansion through tumor‐macrophage crosstalk by activating HIF‐1α and enhancing MIF‐CD44/CD74 signaling. This reprograms TAMs to boost MHC‐I antigen presentation, and CDK4/6 inhibitor‐trained M1 TAM supernatant therapy synergizes with low‐dose PD‐1 blockade to restore antitumor immunity.
Lin He   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy